VF
COCP icon

Virtu Financial’s Cocrystal Pharma COCP Stock Holding History

Virtu Financial’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,080
Closed -$13K – 1699
2026
Q1 		$13K Buy
+13,080
New +$13.5K ﹤0.01% 1439
2022
Q4 		– Sell
-4,001
Closed -$14K – 1694
2022
Q3 		$14K Buy
+4,001
New +$18.7K ﹤0.01% 1469
2022
Q2 		– Sell
-1,186
Closed -$8K – 1645
2022
Q1 		$8K Buy
+1,186
New +$7.89K ﹤0.01% 1376
2021
Q4 		– Sell
-1,561
Closed -$20K – 1776
2021
Q3 		$20K Sell
1,561
-8,158
-84% -$108K ﹤0.01% 1381
2021
Q2 		$146K Buy
9,719
+3,275
+51% +$49.8K 0.01% 1101
2021
Q1 		$107K Buy
6,444
+3,578
+125% +$72.7K 0.01% 1299
2020
Q4 		$47K Sell
2,866
-4,774
-62% -$66.3K 0.01% 1240
2020
Q3 		$85K Buy
+7,640
New +$139K 0.01% 738
2019
Q4 		$14K Buy
+2,362
New +$23.6K ﹤0.01% 1352

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial's COCP Position: Q2 2026 in Review

Virtu Financial sold out of Cocrystal Pharma (COCP) in Q2 2026, closing a stake of 13,080 shares — an estimated $13K sold.

Virtu Financial first reported a position in COCP in Q4 2019 and held it in 9 quarters. The position peaked at $146K in Q2 2021. 27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • Virtu Financial reported no remaining Cocrystal Pharma position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 13,080 Cocrystal Pharma shares in Q2 2026, an estimated $13K.
  • Virtu Financial first reported a position in Cocrystal Pharma in Q4 2019 and held it in 9 quarters.
  • Virtu Financial's Cocrystal Pharma position peaked at $146K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.